2011 annual financial data

Supernus Pharmaceuticals 2011 Net margin

Supernus Pharmaceuticals 2011 net margin with verified reported values.

Direct answer

Net margin was 6,974.22%.

Operating income was -37,752,000 USD and net income was 56,003,000 USD.
Operating cash flow was -36,185,000 USD.

Get free Supernus Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
803,000 USD
Operating income
-37,752,000 USD
Net income
56,003,000 USD
Operating cash flow
-36,185,000 USD